The current situation seems to show that psychedelics-assisted therapy eventually becomes part of the healthcare system for people suffering from a variety of mental and physical disorders, with the latest and most notable examples in Alberta, Canada and Oregon.
Newly introduced to the psychedelics realm, the American Psychedelic Practitioners Association (APPA) is a non-profit organization led by psychiatrists, psychologists, therapists, lawyers, professors, researchers and healers of traditional medicine endorse for safe, effective and accessible care for people with mental illness who can benefit from this type of professionally supervised therapeutic treatment.
The Association will provide support, education, community and mentoring to the psychedelic community while creating consensus on standards of care and training, as well as ethical guidelines for practice.
Members have access to a professional network, mentorship program, events and forums, while Founding Members help shape the regulations and infrastructure for the therapy’s upcoming entry into the US healthcare system. The 15th Horizons Perspective on Psychedelics Conference in New York City will be the scenario for APPA’s call to action for individuals to join the organization.
APPA Managing Director dr Alex Cardenas stated that the goal of the organization is to reunite “the dispersed and diverse psychedelic practitioner community” to further establish, develop, and legitimize the field against persistent negative stereotypes surrounding psychedelics use.
“By setting standards, guidelines and accrediting training programs while working with partner organizations focused on certifying practitioners, we hope to reassure the public and policy makers that psychedelics-assisted therapy is an evidence-based and expert-informed option for their treatment is provided by trained and competent practitioners,” concluded…
